Dynavax Technologies Corporation (DVAX)

Add to Watchlists Create an Alert
2.54 +0.01  +0.40%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

Dynavax Technologies Corporation Shareholders Equity:

97.93M for Dec. 31, 2012
View Full Chart

Dynavax Technologies Corporation Shareholders Equity Chart

    Dynavax Technologies Corporation Historical Shareholders Equity Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 97.93M
    Dec. 31, 2012 114.83M
    Sept. 30, 2012 130.06M
    June 30, 2012 144.71M
    March 31, 2012 88.38M
    Dec. 31, 2011 99.88M
    Sept. 30, 2011 36.23M
    June 30, 2011 45.83M
    March 31, 2011 36.50M
    Dec. 31, 2010 52.11M
    Sept. 30, 2010 23.21M
    June 30, 2010 12.81M
    March 31, 2010 -1.799M
    Dec. 31, 2009 6.376M
    Sept. 30, 2009 18.08M
    June 30, 2009 23.97M
    March 31, 2009 18.74M
    Dec. 31, 2008 13.52M
    Sept. 30, 2008 9.802M
       
    June 30, 2008 13.81M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro

    About Shareholders' Equity

    Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
    Learn More

    Get data for

    DVAX Shareholders Equity Benchmarks

    Companies
    GlaxoSmithKline 10.17B
    Anika Therapeutics 112.83M
    Array BioPharma -31.72M

    DVAX Shareholders Equity Rankings

    Overall 59th percentile
    3262 of 8009
    Sector 64th percentile
    247 of 687 in Healthcare
    Industry 77th percentile
    57 of 248 in Biotechnology

    DVAX Shareholders Equity Range, Past 5 Years

    Minimum -1.799M Mar 2010
    Maximum 144.71M Jun 2012
    Average 49.25M